Cargando…
Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial
BACKGROUND: Two most important factors determining treatment success in chronic myeloid leukemia (CML) are adequate medication compliance and molecular monitoring albeit still being suboptimal. The CMyLife platform is an eHealth innovation, co-created with and for CML patients, aiming to improve the...
Autores principales: | Verweij, Lynn, Ector, Geneviève I. C. G., Smit, Yolba, van Vlijmen, Bas, van der Reijden, Bert A., Hermens, Rosella P. M. G., Blijlevens, Nicole M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994406/ https://www.ncbi.nlm.nih.gov/pubmed/36890512 http://dx.doi.org/10.1186/s12913-023-09153-9 |
Ejemplares similares
-
Improvement, Implementation, and Evaluation of the CMyLife Digital Care Platform: Participatory Action Research Approach
por: Verweij, Lynn, et al.
Publicado: (2023) -
A comprehensive eHealth implementation guide constructed on a qualitative case study on barriers and facilitators of the digital care platform CMyLife
por: Verweij, Lynn, et al.
Publicado: (2022) -
The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach
por: Ector, Geneviève ICG, et al.
Publicado: (2020) -
PB1911: A COMPREHENSIVE EHEALTH IMPLEMENTTION GUIDE CONSTRUCTED ON A QUALITATIVE CASE STUDY ON BARRIERS AND FACILITATORS OF THE DIGITAL CARE PLATFORM CMYLIFE, FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA
por: Verweij, L., et al.
Publicado: (2022) -
PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
por: Djodikromo, Melissa, et al.
Publicado: (2023)